Related Products

Dexell VUR Injectable implant for the treatment of Vesicoureteral Reflux

02182
Temporarily unavailable
12-17 days
I'm interested
Blank page

Dexell VUR Injectable implant for the treatment of Vesicoureteral Reflux
Vesicoureteral reflux (VUR) is the retrograde passage of urine from the bladder into the upper urinary tract. It is the most common urological diagnosis in children, occurring in approximately 1 % of newborns and as high as 30 to 45% in children with UTI. Additionally, there is a high association between VUR, UTI, hypertension and renal damage.

Treatment Options

Conventional Low Dose Antibiotic Therapy

Extended treatment time

Minimally invasive

Patient-parent non-compliance

Risk of antibiotic resistance

Break through UTI

Surgical Ureter Reimplantation

Reimplantation of ureter into bladder

High success rate

Endoscopic injection of Dextranomer/Hyaluronic Acid Injection
lmmediate correction of VUR

High success rate

Endoscopic correction of VUR offers a minimally invasive, day case procedure with a very low risk of complications compared to open surgery


Παιδίατροι
Κλινικές Νοσοκομεία
Ουρολόγοι
Εταιρειες Ιατρικών
Return
Product added to wishlist

The site uses cookies for the best user experience.

To ensure the proper functioning of the site, we sometimes place small data files on your computer, called cookies.
Most large sites do the same.